Clear cell carcinoma of the human ovary synthesizes and secretes a transferrin with microheterogeneity of lectin affinity  by Ohkawa, Kiyoshi et al.
Volume 270, number 1,2, 19-23 FEBS 08829 September 1990 
Clear cell carcinoma of the human ovary synthesizes and secretes a
transferrin with microheterogeneity of lectin affinity 
Kiyoshi Ohkawa’, Koji Takada’, Naoko Takizawal, Takashi Hatanol, Yutaka Tsukada2 and 
Makoto Matsuda’ 
‘Department of Biochemistry, Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato ku, Tokyo, 105, Japan and 
2Department of Biomedical Research, Special Reference Laboratory, Inc., Tokyo 192, Japan 
Received 27 June 1990 
Human ovarian clear cell carcinoma cell line (transferrin (Tf)-non-producer), HAC 2, cells were adapted to grow in chemically defined synthetic 
medium when the cells were cultured with medium containing 10 pg/ml of insulin at least for 6 months. They synthesized and secreted constantly 
the 80 kDa protein immunologically similar to human serum Tf (15 f 12 ng/ml/lO’ cells/3 days). By sensitive lectin-affinity electrophoresis followed 
by antibody-affinity blotting technique, a concanavalin A weakly bound or unbound, lentil lectin, a strongly reactive abnormal band, which was 
rarely found in human serum Tf, was detectable in the Tf synthesized by HAC 2 cells (HACTf). These fmdings suggest hat the HACTf may act 
as one of the autocrine growth factors and that this heterogeneity of HACTf for lectin affinity is ascribed to differences in the carbohydrate moiety 
of the Tf. 
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1. INTRODUCTION 
Transferrin (Tf), the major iron-transporting serum 
glycoprotein of 80 kDa in vertebrate, is known as the 
growth factor required for all proliferating cells in vitro 
[1,2] and in vivo [3]. Tf is mainly synthesized in liver 
parenchymal cells but is also synthesized in other cells 
(myoblast (41, chorioid plexus [5], oligodendroglia [6], 
lymphocyte [7], yolk sac endoderm [8], and Sertoli cells 
[9]) as reported previously. Transformed cells in the 
malignant tissues described above also possessed the 
ability to producing the Tf at various degrees [lo, 111. 
Additionally few reports have been documented that Tf 
is also synthesized in the various cancerous cells as one 
of the autocrine growth factors, such as lung cancer [ 121 
and breast cancer [13]. The possibility has been also 
reported that the carbohydrate moieties of each Tf dif- 
fered from others [6]. To characterize the Tf synthesiz- 
ed by Tf-non-producer cells, we reported here that 
another case of cancer cell, ovarian clear cell carcinoma 
cell line, HAC 2, was able to synthesize the 80 kDa pro- 
tein (HACTf) with immunoreacting to human Tf with 
heterogeneity of lectin-affinity. 
2. MATERIALS AND METHODS 
2.1. Cell line 
Human ovarian clear cell carcinoma cell line, HAC 2, was kindly 
provided by Dr. M. Nishita, Tsukuba University School of Medicine 
Correspondence address: K. Ohkawa, Department of Biochemistry, 
Jikei University School of Medicine, 3-25-8, Nishi-shinbashi, Minato 
ku, Tokyo 105, Japan 
and was maintained in RPM1 1640 supplemented with 10% fetal 
bovine serum (FBS, Flow Lab. North Ryde, Australia). For adapta- 
tion of HAC 2 clone to serum-free chemically defined synthetic 
medium supplemented with NasSeGp (ISRPMI) which was reported 
previously [14], the cells were initially transferred to ISRPMI with ad- 
dition of insulin (10 &ml, Sigma, St. Louis, MO, USA) and cultured 
over 6 months. From the 8th week of culturing time, a HAC 2 cell 
clone was able to replicate continuously but slowly in ISRPMI 
without addition of insulin. Conditioned media obtained from each 
culture were stocked at - 80°C until use. 
2.2. Antibody against human Tf 
Polycloncal goat antibody against human Tf was obtained from 
Cappel (No. 0201-1441, Lot 32730. Organon Teknika, West Chester, 
PA, USA). Monospecificity of the antibody was checked by im- 
munoelectrophoresis. Specific antibody against human Tf was 
purified by affinity chromatography on BrCN-activated Sepharose 
4B (Pharmacia, Uppsala, Sweden) coupled to human Tf (Sigma). 
Briefly, 20 ml (20 mg/ml) antibody was passed through the affinity 
column at a flow rate of 10 ml/h. The column was washed with 10 
mM Na-phosphate buffer, pH 7.0, 0.5 M NaCl, 0.02% NaNs, and 1 
mM PMSF (wash buffer) and eluted by 3 M MgCh in wash buffer. 
The eluate was dialyzed against 10 mM Na-phosphate buffer, pH 7.0, 
0.15 M NaCl, 0.02% NaNs and 1 mM PMSF (PBS) for 24 h at 4°C. 
Biotinylation of the antibody was performed by the method described 
by Guesdon et al. [15]. Briefly, the specific antibody was dialyzed 
against 0.1 M NaHCOp containing 0.5 M NaCl at 4°C overnight. One 
ml of the dialyzed antibody (1 mg/ml) was mixed with 100 ~1 of N- 
hydroxysuccinimidobiotin (Pierce Chemical, Rockford, IL, USA) 
dissolved in dimethylsulfoxide (DMSO, 1 mg/ml). The mixture was 
incubated for 4 h at room temperature and then extensively dialyzed 
against 20 mM Tris HCI, pH 7.5, 0.5 M NaCI, 0.01% sodium mer- 
thiolate (TBS) at 4°C overnight. 
2.3. Enzyme-linked immunosorbent assay (ELISA) for human Tf 
96 well microtiter plates (Nunc, Denmark) with 10 pg/ml im- 
mobilized specific antibody against human Tf were incubated with 
standard human Tf (Sigma) or conditioned media at 4°C overnight. 
Wells were then incubated with biotinylated anti-human Tf antibody 
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(2 pg/ml in 0.05% Tween 20 in TBS) for 5 h at room temperature 
followed by avidin-conjugated horseradish peroxidase (HRP, 2 Fg/ml 
in 0.1 M NaHCOs, Cappel) for 30 min at room temperature. 
Substrate reaction using O-phenylendiamine was determined at 492 
nm in a microplate reader, MRP A4 (TOSOH, Tokyo, Japan). 
2.4. Purification of HACTf 
HAC 2 conditioned media were loaded onto the specific anti- 
human Tf IgG-coupled Sepharose 4B (Pharmacia) column. The col- 
umn was washed with wash buffer and the Tf was eluted by 8 M urea 
in PBS. The eluate was extensively dialyzed against PBS at 4°C for 24 
h. Tf from normal human serum was also prepared by this method. 
2.5. Sodium dodecyl sulfate polyacrylamide gel electrophoresis 
(SDS-PAGE) 
SDS-PAGE was carried out using 7.5% gel according to Laemmli 
1161. The resulting gel was stained by either Coomassie blue or silver 
staining kit (BioRad, Richmond, CA, USA). For molecular weight 
markers we used protein markers (BioRad) with ovalbumin (43 kDa), 
bovine serum albumin (66.2 kDa) and phosphorylase b (97.4 kDa). 
2.6. Metabolic labelling and immunoprecipitation of HACTf 
HAC 2 cells cultured with ISRPMI in 75 cm2 flasks (Falcon No. 
3084, Oxnard, CA, USA) were once washed with Dulbecco’s PBS and 
were incubated in L-leucine-free minimum essential medium (GIB- 
CO, NY, USA) supplemented with NazSeOs and L-glutamine; after 
60 min the media were discarded and [‘?I-L-leucine (5 
pCi/ml,sp.act. 12.5 GBq/mmol, Amersham, Tokyo, Japan) in the 
same medium were added to the flasks and further cultivated for 24 
h. After incubation, the conditioned media were stocked, dialyzed 
against PBS, concentrated by ultrafiltration (Amicon, Danvers, MA, 
USA). 20 ~1 (1 mg/ml) of goat anti-human Tf IgG or preimmune goat 
IgG was added to the concentrated conditioned media containing 
25,340 cpm of radiolabeled proteins in 20 mM Tris-HCI, pH 7.4,O. 15 
M NaCl, 1% Triton X-100, 1% sodium deoxycholate. After 24 h in- 
cubation at 4”C, 50 ~1 of rabbit antibody against goat IgG (1 mg/ml) 
was added and incubation was continued for an additional 24 h at 
4°C. The immunoprecipitates were collected by centrifugation at 3000 
rpm for 30 min through a 1 ml cushion of 1 M sucrose in PBS and 
washed 4 times with 0.05% Tween 20 in TBS. The im- 
munoprecipitates were dissolved in 40 ~1 of SDS sample buffer (1% 
Fig. 1. Fluorograph of metabolically radiolabelled protein 
synthesized and secreted by HAC 2 cells. Immunoprecipitation by 
anti-human Tf antibody shown in lane 1 and by preimmune goat IgG 
shown in lane 2. Molecular weight markers in kDa. 
September 1990 
SDS, 1% 2-mercaptoethanol, 4 M urea in 0.0625 M Tris-HCl, pH 6.8) 
by boiling for 10 min and centrifuged in Eppendorf microtubes. Ali- 
quots were subjected to SDS-PAGE and the gels were fixed, stained 
by Coomassie blue. Destained gels were incubated with DMSO, 
treated with 22.2 (w/v) 2,5-diphenyloxazole in DMSO for 3 h, soaked 
in water to remove DMSO, dried and exposed to X-ray film (Fuji, 
Tokyo, Japan) at - 70°C for fluorography [17]. 
2.7. Lectin-affinity electrophoresis and antibody-affinity blotting 
analysis for fractionation of molecular species of HACTf 
HACTf was fractionated by concanavalin A (ConA, Hohnen, 
Tokyo, Japan) or lentil lectin (LcHA, Hohnen, Tokyo, Japan) affini- 
ty agarose electrophoresis followed by antibody affinity blotting as 
described previously (181. Briefly, antibody-coated nitrocellulose 
papers were prepared by incubation with 100 pg/ml specific goat an- 
tibody to human Tf for 30 min, then by fixing with glutaraldehyde 
vapour for 30 min, neutralizing for 3 min with NaBH4, followed by 
washing with TBS. The nitrocellulose paper was blocked with 0.5% 
Tween 20 in TBS for 30 min, then washed with TBS. 
Electrophoresis was performed on 1.0% agarose gel plates (Litex 
type HSA, Denmark) in Tris/barbital buffer (pH 8.6, ionic strength 
0.02) containing either 0.1 mg/cm2 ConA or 20 pg/cm2 LcHA. 1~1 of 
100 ng/ml samples were electrophoresed on the plates at 4°C at a 
voltage gradient of 15 V/cm. After lectin affinity electrophoresis, 
HACTf was transferred by capillary blotting to nitrocellulose paper 
coated with antibody to human Tf. The nitrocellulose paper was then 
washed twice in 0.05% Tween 20 in TBS, treated with rabbit anti- 
human Tf IgG (Dakopatts, Glostrup, Denmark), followed by treat- 
ment with swine antibody to rabbit IgG labelled with HRP 
(Dakopatts). Color was developed by incubating the nitrocellulose 
paper with 3,3 ‘-diaminobenzidine tetrachloride (Polyscience, Warr- 
ington, PA, USA) and Hz02 in TBS. After color development, he 
membranes were washed, dried and scanned with densitometer 
(Dualwavelength, Flying-spot scanner CS-9000, Shimazu, Tokyo, 
Japan) at 495 nm. 
2.8. Chemicals 
All other chemicals were used of reagent grade. 
3. RESULTS 
3.1, Determination of HACTf in culture medium 
The secretion of Tf was not detectable by ELISA 
when HAC 2 cells were cultured with either FBS- 
C-l c-2 c-3 
NHS 
NHS 
L-l L-2 L-3 
Fig. 2. SDS-PAGE of purified Tf from conditioned medium of HAC 
2 (lane 1) or from normal human serum (lane 2). Molecular weight 
markers in kDa. 
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Fig. 3. Analytical Tf bands separated by ConA, or LcHA-affinity 
electrophoresis. Tf from HAC and from normal human serum 
(NHS). Each 1 ~1 sample was applied and electrophoresis was run 
until bromophenol blue migrated 9.0 cm from the origin (-). 
C-l-C-3 and L-l-L-3 are described in the text. 
containing RPM11640 or ISRPMI without insulin. 
Detection of Tf secretion into the culture media, when 
HAC 2 cells were cultured in ISRPMI containing in- 
sulin, indicated that the synthesis and secretion of Tf in- 
-reased gradually reaching detectable levels of 15 rt 12 
g/ml/lO’ cells/3 days and then remained at a constant 
eve1 without addition of insulin to culture medium. 
3.2. Immunoprecipitation f HACTf 
In order to evaluate this protein synthesized, secreted 
from HAC 2 cells, immunoprecipitation with anti- 
human Tf antibody was carried out. The 80 kDa labell- 
ed protein was immunoprecipitated with antibody (Fig. 
1). The electrophoretic protein profile of the condition- 
ed media after the immunoprecipitation lacked the 80 
kDa protein band (data not shown), indicating that 
most, if not all, of the 80 kDa protein was immunoreac- 
tive with the antibody against human Tf. 
3.3. Immunoaffinity purification of HACTf 
Tf synthesized and secreted by HAC 2 cells, 
separated by single step immunoaffinity column, was 
obtained with an average amount of 700 ng/50 ml con- 
ditioned media. This fraction gave a single band with 
molecular weight of 80 kDa by SDS-PAGE analysis 
(Fig. 2). 
3.4. Lectin-affinity electrophoresis and antibody- 
affinity blotting analysis of HACTf 
Lectin affinity-crossed immunoelectrophoresis which 
is a more quantitative technique but has a low sensitivi- 
ty was not applied in this study because of the low levels 
of Tf in the culture media (ca 14 pg/l). Testing the af- 
finity of antibody-coated nitrocellulose paper by dot- 
blot analysis of human Tf (Sigma) serially diluted with 
1% bovine serum albumin in TBS, as low as 3 ng (1 ~1 
of 3 pg/ml) Tf was detected with the dose-dependent 
color intensity. In contrast, using the plain 
nitrocellulose paper without coating of antibody show- 
ed lOO-fold lower sensitivity for the detection of Tf 
without any dose-dependent color reaction (data not 
shown). By this sensitive method after ConA-affinity 
electrophoresis. Tf derived from normal human serum 
was resolved into 3 bands, i.e. strongly ConA reactive 
major (C-l), moderately reactive minor (C-2), and non- 
reactive slight but detectable (C-3) (Fig. 3) and the same 
HAC NHS Distance HAC NHS 
LcHA 
Fig. 4. Densitometric analysis was carried out according to the Materials and Methods. See Fig. 3 for other keys. 
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results were also obtained from the densitometric 
analysis (Fig. 4). This result is compatible with the pro- 
file obtained from ConA-affinity crossed immunoelec- 
trophoresis of normal human serum Tf as previously 
mentioned [19]. HACTf was resolved mainly into 3 
bands with significant increase of C-3 (Fig. 3). Addi- 
tionally by the densitometric analyses, C-l showed the 
shoulder-like peak and the increased amounts of 
another fraction between C-l and C-2 was suggested 
(Fig. 4). More obvious difference of the electrophoretic 
profile between normal human serum Tf and HACTf 
was noted in LcHA-affinity electrophoresis. As shown 
in Figs 3 and 4, normal human serum Tf was separated 
into 3 bands of LcHA unreactive major (L-3) and weak- 
ly reactive minor (L-2) and strongly reactive but quite 
minor (L-l) Tf. In contrast, HACTf was also frac- 
tionated into 3 bands with significant increasing of 
LcHA reactive fractions. Among them, 2 bands (L-2 
and L-3) probably corresponded to those of normal 
human serum Tf because of the same electrophoretic 
pattern. However, the third band (L-l) showed the pro- 
perty of high affinity to LcHA which was specific to 
HACTf. These results suggest hat HACTf consists of 
Tf showing the heterogeneity with lectin-affinity due to 
differences in the carbohydrate moiety. 
4. DISCUSSION 
We have shown that the human ovarian clear cell car- 
cinoma cell line, HAC 2, was able to synthesize and 
secrete significant amounts of 80 kDa protein into the 
chemically defined synthetic medium, ISRPMI. The 
protein shared immunoreactivity and molecular weight 
with purified human serum Tf. The initial addition of 
insulin to the medium was effective to adapt the HAC 
2 cells to serum-free ISRPMI because the production of 
detectable amounts of Tf was induced and the syn- 
thesized Tf probably acted as a growth factor. It has 
been reported that the expression of Tf receptor was in- 
duced by the insulin or insulin-like growth factor(s) 
after the expression of Tf [ 121. In our study Tf receptor 
had not been checked. 
Reactivities to ConA as well as LcHA of HACTf 
were different from those of normal human serum Tf 
determined by the sensitive assay method of antibody- 
affinity blotting. Increased amounts of ConA-weakly 
(C-2) and -non-reactive (C-3) bands whith the ap- 
pearance of another band between them was noted. 
Moreover, LcHA-strongly reactive band (L-l) was 
clearly detectable in the HACTf. These findings suggest 
that glycosylation of Tf in HAC2 cell differs from that 
in normal hepatocyte. The known carbohydrate chain 
specificities of ConA and LcHA are different. The 
oligosaccharide structure required for LcHA reactivity 
lies in the core fucose attached to GlcNAc [20]. In con- 
trast, this structure of additional fucose attachment o 
GlcNAc does not influence the reactivity to ConA, but 
22 
the increasing of tri- and tetra-antennary glycosylation 
of carbohydrate moieties of Tf molecules diminishes 
the affinity to ConA [21]. This fact concluded that the 
fucosylated Tf in highly branched glycans increased in 
HACTf molecules. The structural heterogeneity of the 
carbohydrate moiety of human serum Tf has been 
reported in some physicopathologic conditions 
[19,22,23] as well as in vitro hepatoma cell line [24]. 
Fucosylation of the carbohydrate moiety of the proteins 
has been demonstrated in some proteins, such as Tf 
[24], a-fetoprotein [25] and y-glutamyl transpeptidase 
[26]. These findings show that fucosylation of the car- 
bohydrate moiety of the glycoproteins is one of the 
characteristics in the expression of cancer cells. The 
syntheses of Tf by HAC2 cells may bestow selective 
growth advantages on these rapidly growing cells and 
Tf acting as autocrine growth factor perhaps permits 
tumor cell growth in metastatic lesions not well 
vascularized in vivo. 
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